Today's Date: May 21, 2013

Contact Us

Investor/Media Information

View contact details for Investor Relations and Media Relations representatives.

Request Investor Information

 

U.S. Adverse Event Reporting

  • Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding TYSABRI® (natalizumab), please contact Biogen Idec at 1-866-MED-INFO (1-866-633-4636) or by e-mail at medinfo@biogenidec.com

  • Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding PRIALT® (ziconitide intrathecal infusion), please contact Jazz Pharmaceuticals at 1-888-774-2581.

  • Health care professionals and consumers with medical information inquiries, product complaints, or adverse event reports regarding MAXIPIME® (cefepime hydrochloride, USP) for Injection or AZACTAM® (aztreonam for injection, USP), please contact Bristol Myers Squibb Medical Information (BMS) at 1-800-321-1335 or by email at  Drug.Information@bms.com

 

Locations

Headquarters
Treasury Building, Lower Grand Canal Street, Dublin 2, Ireland
TEL (353) 1 709 4000, FAX (353) 1 709 4700

300 Technology Square, Third Floor, Cambridge, MA 02139
TEL (800) 252 3526, FAX (617) 715 8281 

Dammstrasse 19, CH-6301, Zug, Switzerland
TEL (41) 41 723 29 30, Fax (41) 41 723 29 40       
 

 

Your feedback is helpful in determining the types of information you would be interested in seeing. Please submit your feedback to website.feedback@elan.com. Do not use the feedback e-mail address to report adverse events (side effects). Please see the Adverse Event Reporting section above. 

 

U.S. Healthcare Professionals

Medical Information Services

For Medical Information, please click here

 

Careers/Job Opportunities

Search for a job with Elan.